在欧洲为医疗目的启用生殖系编辑需要什么?
1Department of Law, Faculty of Law, Uppsala University Box 256, 751 05 Uppsala Sweden.
European journal of health law
|August 15, 2023
概括
由于伦理问题,欧洲法规目前禁止人类生殖系基因编辑. 实现这种医疗技术需要对这些禁令的基本价值观和原则进行根本性的转变.
科学领域:
- 生物医学伦理 生物医学伦理
- 欧盟法律 欧盟法律
- 基因工程是一种基因工程.
背景情况:
- 目前的欧洲法规,包括"人权与生物医学公约"和欧盟临床试验法规,禁止人类生殖基因编辑.
- 这些禁令反映了欧洲对生殖干预的伦理和法律影响的历史立场.
- 最近的进展,特别是CRISPR-Cas技术,创造了新的可能性,需要对现有的法律框架进行重新评估.
研究的目的:
- 检查在欧洲为医疗应用而启用人类生殖基因编辑的要求.
- 仔细审查现有的禁令,并探索可能解除禁令的机制.
- 分析塑造当前监管格局的基本价值和原则.
主要方法:
- 对欧洲禁止生殖系编辑的法律分析.
- 检查当前法规背后的伦理和法律原则.
- 评估监管变革的潜在途径.
主要成果:
- 欧洲现有的禁止人类生殖基因编辑的禁令深深植根于既定的法律和道德结构中.
- 取消这些禁令需要对基本价值观和原则进行重大重新评估和潜在的转变.
- 当前解除禁令的法律机制在没有改变其基础的伦理和社会方法的情况下是不够的.
结论:
- 改变对核心价值观和原则的方法对于使人类生殖基因编辑在欧洲成为可能至关重要.
- 克服监管障碍需要更广泛的社会和道德对话.
- 未来的生殖基因编辑启用取决于将基础的伦理框架适应新的科学现实.
更多相关视频
09:37Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development
Published on: March 5, 2017
13.2K
08:22CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
Published on: March 12, 2018
14.9K
相关概念视频
What is Genetic Engineering?
74.4K
Overview
74.4K
CRISPR
52.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.3K
In-vitro Mutagenesis
14.0K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.0K
